Test Catalog
Clinical-grade molecular diagnostic tests for hereditary cancer risk, neurodegenerative diseases, drug response, and advanced liquid biopsy.
16S rRNA Gene Sequencing
Targeted bacterial microbiome profiling using 16S rRNA amplicon sequencing
Alzheimer's Disease Plasma Biomarker Panel
Validated plasma biomarkers for Alzheimer's disease — aligned with NIA-AA 2024 criteria
CoGenesis® ASD
A comprehensive ASD and neurodevelopmental panel-1,255 SFARI-curated genes
CoGenesis® BRCA-Pro
29-gene hereditary breast and ovarian cancer test
CoGenesis® CVD
Comprehensive hereditary cardiovascular disease panel
CoGenesis® Ciliopathies
NGS virtual panel covering 237 genes across 6 disease panels (Ciliopathies)
CoGenesis® Colo
31-gene hereditary colorectal cancer test
CoGenesis® Dermatological
NGS virtual panel covering 163 genes across 13 disease panels (Dermatological disorders)
CoGenesis® Drug Response
Pharmacogenomics for drug personalisation
CoGenesis® Dysmorphic & congenital abnormality syndromes
NGS virtual panel covering 758 genes across 10 disease panels (Dysmorphic and congenital abnormality syndromes)
CoGenesis® Endocrine
NGS virtual panel covering 436 genes across 14 disease panels (Endocrine disorders)
CoGenesis® Gastric
34-gene hereditary gastric cancer test
CoGenesis® Gastroenterological
NGS virtual panel covering 312 genes across 6 disease panels (Gastroenterological disorders)
CoGenesis® Growth Disorders
NGS virtual panel covering 36 genes across 2 disease panels (Growth disorders)
CoGenesis® Haematological
NGS virtual panel covering 270 genes across 4 disease panels (Haematological disorders)
CoGenesis® Hearing & Ear
NGS virtual panel covering 589 genes across 4 disease panels (Hearing and ear disorders)
CoGenesis® Metabolic
NGS virtual panel covering 1001 genes across 9 disease panels (Metabolic disorders)
CoGenesis® NF1/NF2
Neurofibromatosis Genetic testing for NF1 and NF2.
CoGenesis® Neuro
Comprehensive genomic panel for unexplained neurological disorders
CoGenesis® Ophthalmological
NGS virtual panel covering 773 genes across 8 disease panels (Ophthalmological disorders)
CoGenesis® Pan-Cancer
123-gene hereditary pan-cancer panel across 10 NCCN-informed subpanels
CoGenesis® Prostate
Hereditary prostate cancer gene panel
CoGenesis® Renal & urinary tract
NGS virtual panel covering 378 genes across 10 disease panels (Renal and urinary tract disorders)
CoGenesis® Respiratory
NGS virtual panel covering 121 genes across 4 disease panels (Respiratory disorders)
CoGenesis® Rheumatological
NGS virtual panel covering 116 genes across 3 disease panels (Rheumatological disorders)
CoGenesis® Skeletal
NGS virtual panel covering 815 genes across 10 disease panels (Skeletal disorders)
Cxbladder® Detect
Risk stratification for microhaematuria — reduce unnecessary cystoscopy
Cxbladder® Monitor
Non-invasive bladder cancer surveillance — reduce cystoscopy burden in NMIBC
Cxbladder® Triage
Urine genomic test to risk-stratify haematuria — AUA Guideline Level A Evidence
Guardant Reveal™
Minimal residual disease (MRD) detection for early-stage cancer surveillance
Guardant Shield™
Blood-based colorectal cancer screening for average-risk adults age 45+.
Guardant360® CDx
First FDA-aproved liquid biopsy for advanced solid tumour treatment guidance
Guardant360® Liquid
Comprehensive liquid biopsy for advanced solid tumour treatment guidance
Guardant360® TissueNext™
Tissue-based comprehensive genomic profiling with digital pathology
Plasma GFAP
Ultra-sensitive blood test for astrocyte injury and neuroinflammation
Plasma NfL (Neurofilament Light Chain)
Universal axonal damage marker for neurodegenerative disease
Plasma p-tau181
Validated plasma biomarker for early Alzheimer's disease tau pathology
Plasma p-tau217
The most specific blood biomarker for Alzheimer's disease pathology
Plasma α-Synuclein
Highly sensitive detection of misfolded α-synuclein for synucleinopathy diagnosis
PrecivityAD2™ (C2N Diagnostics)
Mass spectrometry blood test combining Aβ42/40 and p-tau217 for Alzheimer's diagnosis
Whole Metagenome Sequencing (mWGS)
shotgun metagenomics for comprehensive microbiome profiling and infectious disease detection
Hong Kong-based molecular diagnostics laboratory specialising in clinical genomics, precision oncology, and rare disease diagnosis. Accredited to ISO 27001 and GenQA standards.
© 2026 Codex Genetics Limited. All rights reserved.
